目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T12912 | Sigma receptor HER | ||
Sigma-1 receptor antagonist 3 是 Sigma-1受体选择性拮抗剂,Ki 为 1.14 nM。它抑制 hERG,IC50为 1.54μM。它在神经性疼痛方面有研究的价值。 | |||
T11966 | HER Melanin-concentrating Hormone Receptor (MCHR) | ||
MCHR1 antagonist 2 是有效的黑色素聚集激素受体 1 拮抗剂,IC50为 65 nM。它也抑制hERG,在IMR-32 细胞中的IC50为 4.0 nM。 | |||
T6245 | Potassium Channel | ||
BAPTA-AM 是一种钙离子螯合剂,具有细胞渗透性和选择性,可以阻断 hERG、hKv1.3 和 hKv1.5 通道 (IC50=1.3/1.45/1.23 μM)。BAPTA-AM对 Ca2+的亲和力是 Mg2+的 105 倍,可以用于钙在细胞信号传导中的作用。 | |||
T16265 | EGFR 5-HT Receptor | ||
Naluzotan(PRX 00023) 是一种新型高效的 5-HT1A 激动剂,IC50 和 Ki 值分别为约 20 nM 和 5.1 nM。Naluzotan 是一种有效的 hERG K+ 通道阻滞剂,IC50 值为 3800 nM。Naluzotan 具有抗焦虑活性,可用于研究抑郁症。 | |||
T6827 | Estrogen Receptor/ERR Potassium Channel Estrogen/progestogen Receptor HER | ||
Endoxifen Z-isomer hydrochloride (Endoxifen HCl) 是Tamoxifen 最重要的代谢产物, 在表达ERα的乳腺癌细胞中发挥抗雌激素作用, Endoxifen HCl 以浓度依赖的方式抑制hERG, IC50值为1.6μM。 | |||
T10556 | EGFR | ||
BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM). | |||
TN2338 | Others | ||
Guan-fu base G is derived from the tuberous root of the Aconitum aurantium plant. |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-02227 | ERG Protein, Human, Recombinant (His) | Human | Yeast | ||
Transcriptional regulator. May participate in transcriptional regulation through the recruitment of SETDB1 histone methyltransferase and subsequent modification of local chromatin structure.
|
|||||
TMPH-03447 | ERG11 Protein, S. cerevisiae, Recombinant (GST) | Saccharomyces cerevisiae | E. coli | ||
Catalyzes C14-demethylation of lanosterol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol.
|
|||||
TMPH-03460 | ERG26 Protein, S. cerevisiae, Recombinant (His & Myc) | SVG-Saccharomyces cerevisiae | E. coli | ||
Essential enzyme in the ergosterol biosynthetic pathway. Part of a 3 enzyme system that catalyzes the sequential removal of the 2 methyl groups at the sterol C-4 position, converting 4,4-dimethylzymosterol to zymosterol. Catalyzes the second step, an oxidative decarboxylation that results in a reduction of the 3-beta-hydroxy group at the C-3 carbon to an oxo group.
|